MX2021011310A - Recubrimientos para formas de dosificacion de residencia gastrica. - Google Patents
Recubrimientos para formas de dosificacion de residencia gastrica.Info
- Publication number
- MX2021011310A MX2021011310A MX2021011310A MX2021011310A MX2021011310A MX 2021011310 A MX2021011310 A MX 2021011310A MX 2021011310 A MX2021011310 A MX 2021011310A MX 2021011310 A MX2021011310 A MX 2021011310A MX 2021011310 A MX2021011310 A MX 2021011310A
- Authority
- MX
- Mexico
- Prior art keywords
- gastric residence
- dosage forms
- coatings
- folded configuration
- residence system
- Prior art date
Links
- 230000002496 gastric effect Effects 0.000 title abstract 7
- 239000002552 dosage form Substances 0.000 title abstract 3
- 239000011248 coating agent Substances 0.000 abstract 2
- 238000000576 coating method Methods 0.000 abstract 2
- 239000003349 gelling agent Substances 0.000 abstract 1
- 239000004014 plasticizer Substances 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
- 210000002784 stomach Anatomy 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
- A61J3/005—Coating of tablets or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
- A61J3/07—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
- A61J3/071—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use into the form of telescopically engaged two-piece capsules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4833—Encapsulating processes; Filling of capsules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/485—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962821361P | 2019-03-20 | 2019-03-20 | |
| PCT/US2020/023710 WO2020191231A1 (en) | 2019-03-20 | 2020-03-19 | Coatings for gastric residence dosage forms |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2021011310A true MX2021011310A (es) | 2021-12-10 |
Family
ID=72519158
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2021011310A MX2021011310A (es) | 2019-03-20 | 2020-03-19 | Recubrimientos para formas de dosificacion de residencia gastrica. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US12582608B2 (enExample) |
| EP (1) | EP3941444B1 (enExample) |
| JP (2) | JP2022525482A (enExample) |
| CN (1) | CN113840596A (enExample) |
| AU (1) | AU2020242062B2 (enExample) |
| BR (1) | BR112021018424A2 (enExample) |
| CA (1) | CA3134186A1 (enExample) |
| IL (1) | IL286510A (enExample) |
| MX (1) | MX2021011310A (enExample) |
| WO (1) | WO2020191231A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020117855A1 (en) | 2018-12-03 | 2020-06-11 | Lyndra, Inc. | Stomach simulating device |
| BR112021018496A2 (pt) | 2019-03-20 | 2021-11-30 | Lyndra Therapeutics Inc | Cápsulas e revestimento de cápsula para formas de dosagem de residência gástrica |
| AU2020242062B2 (en) | 2019-03-20 | 2025-12-11 | Nortiva Bio, Inc. | Coatings for gastric residence dosage forms |
| JP7847119B2 (ja) | 2020-07-29 | 2026-04-16 | ザ・セカント・グループ・エルエルシー | 架橋ポリ（セバシン酸グリセロール）を含む構造を含む形状誘導型制御放出および保持 |
| WO2024225479A1 (ja) * | 2023-04-28 | 2024-10-31 | クオリカプス株式会社 | バンドシール液、バンドシール、ゼラチン硬質カプセルの封緘方法、及びゼラチン硬質カプセル製品 |
Family Cites Families (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9706149D0 (en) * | 1997-03-25 | 1997-05-14 | Scherer Corp R P | Comestible capsules having flavoured coatings |
| WO2003051304A2 (en) | 2001-12-15 | 2003-06-26 | Spherics, Inc. | Bioadhesive drug delivery system with enhanced gastric retention |
| DK1578350T3 (da) | 2002-03-26 | 2009-08-10 | Euro Celtique Sa | Sammensætninger med gel-coating med depotvirkning |
| IL166183A0 (en) | 2005-01-06 | 2006-01-15 | Yissum Res Dev Co | Novel diagnostic and imaging techniques of the gi tract |
| KR20080005429A (ko) * | 2005-04-19 | 2008-01-11 | 알자 코포레이션 | 트라마돌 및 가바펜틴을 포함하는 물질의 배합물 |
| WO2007002518A1 (en) | 2005-06-23 | 2007-01-04 | Spherics, Inc. | Delayed release or extended-delayed release dosage forms of pramipexole |
| JP4948828B2 (ja) | 2005-11-28 | 2012-06-06 | 森下仁丹株式会社 | 胃内浮遊滞留シームレスカプセルとその製造方法 |
| CA2675230A1 (en) | 2006-01-10 | 2008-07-26 | Pipex, Inc. | Pharmaceutical compositions and methods to achieve and maintain a targeted and stable copper status and prevent and treat copper-related central nervous system diseases |
| EP2997953B1 (en) | 2006-01-18 | 2018-12-26 | Intec Pharma Ltd. | Delivery device for oral intake of an agent |
| WO2007093999A1 (en) * | 2006-02-15 | 2007-08-23 | Intec Pharma Ltd. | A gastro-retentive system for the delivery of macromolecules |
| JP2012500230A (ja) * | 2008-08-18 | 2012-01-05 | 北京天衡▲薬▼物研究院 | 胃内滞留薬物放出システム及びその製造方法と使用 |
| US8006033B2 (en) | 2008-09-09 | 2011-08-23 | Intel Corporation | Systems, methods, and apparatuses for in-band data mask bit transmission |
| CA2745741A1 (en) | 2008-12-04 | 2010-06-10 | Intec Pharma Ltd. | Zaleplon gastroretentive drug delivery system |
| US8414559B2 (en) | 2009-05-07 | 2013-04-09 | Rainbow Medical Ltd. | Gastroretentive duodenal pill |
| EP2490677A2 (en) | 2009-10-19 | 2012-08-29 | Intec Pharma Ltd. | Novel gastroretentive dosage forms of poorly soluble drugs |
| CA2825917C (en) | 2011-02-14 | 2016-08-30 | The Procter & Gamble Company | Filmcoated solid dosage forms comprising honey in the coating |
| WO2014035639A1 (en) | 2012-08-29 | 2014-03-06 | Cardiac Pacemakers, Inc. | Enhanced low friction coating for medical leads and methods of making |
| WO2015187746A1 (en) | 2014-06-02 | 2015-12-10 | Teva Pharmaceutical Industries Ltd. | Expandable gastroretentive dosage form |
| NZ727659A (en) | 2014-06-11 | 2021-12-24 | Massachusetts Inst Technology | Residence structures and related methods |
| US20170266112A1 (en) | 2014-06-11 | 2017-09-21 | Massachusetts Institute Of Technology | Residence structures and related methods |
| WO2015195989A1 (en) * | 2014-06-20 | 2015-12-23 | Banner Life Sciences Llc | Enteric soft capsule compositions |
| EP3288604B1 (en) | 2015-05-01 | 2021-11-17 | Massachusetts Institute of Technology | Triggerable shape memory induction devices |
| MX387092B (es) | 2015-06-17 | 2025-03-19 | Biogen Ma Inc | Particulas de dimetilfumarato y composiciones farmaceuticas de estas. |
| US20190000768A1 (en) | 2015-08-04 | 2019-01-03 | Fuji Capsule Co., Ltd. | Enteric capsule |
| US11576859B2 (en) | 2015-10-23 | 2023-02-14 | Lyndra Therapeutics, Inc. | Gastric residence systems for sustained release of therapeutic agents and methods of use thereof |
| WO2017100367A1 (en) | 2015-12-08 | 2017-06-15 | Lyndra, Inc. | Geometric configurations for gastric residence systems |
| CN109310639A (zh) | 2016-05-27 | 2019-02-05 | 林德拉有限公司 | 用于胃驻留系统的材料结构 |
| JP2019532947A (ja) | 2016-09-30 | 2019-11-14 | リンドラ，インコーポレイティド | アダマンタン系薬物の持続的送達のための胃内滞留システム |
| CN110035718B (zh) * | 2016-12-02 | 2021-04-06 | 克雷西奥生物科技有限公司 | 胃内滞留系统 |
| CA3066658A1 (en) | 2017-06-09 | 2018-12-13 | Lyndra, Inc. | Gastric residence systems with release rate-modulating films |
| US11793751B2 (en) | 2017-09-20 | 2023-10-24 | Lyndra Therapeutics, Inc. | Encapsulation of gastric residence systems |
| JP2021535090A (ja) | 2018-08-15 | 2021-12-16 | リンドラ セラピューティクス， インコーポレイティド | 治療薬物の腸内送達のためのシステム |
| WO2020117855A1 (en) | 2018-12-03 | 2020-06-11 | Lyndra, Inc. | Stomach simulating device |
| AU2020242062B2 (en) | 2019-03-20 | 2025-12-11 | Nortiva Bio, Inc. | Coatings for gastric residence dosage forms |
| BR112021018496A2 (pt) | 2019-03-20 | 2021-11-30 | Lyndra Therapeutics Inc | Cápsulas e revestimento de cápsula para formas de dosagem de residência gástrica |
| WO2021092486A1 (en) | 2019-11-08 | 2021-05-14 | Lyndra, Inc. | Formulations for release-rate modulating films for gastric residence systems |
| IL292848A (en) | 2019-11-08 | 2022-07-01 | Lyndra Therapeutics Inc | Polymeric linkers for a gastric residence system |
| JP2022553867A (ja) | 2019-11-08 | 2022-12-26 | リンドラ セラピューティクス， インコーポレイティド | 胃内滞留を改善するフィラメントを有する胃内滞留システム |
| MX2022005494A (es) | 2019-11-08 | 2022-08-11 | Lyndra Therapeutics Inc | Sistemas de residencia gastrica para la administracion de agentes activos. |
| US20220387312A1 (en) | 2019-11-08 | 2022-12-08 | Lyndra Therapeutics, Inc. | Gastric residence systems having arms with controlled stiffness for improved gastric residence |
| US20240390270A1 (en) | 2021-01-19 | 2024-11-28 | Lyndra Therapeutics, Inc. | Gastric residence systems for administration of risperidone |
| JP2024517829A (ja) | 2021-05-05 | 2024-04-23 | リンドラ セラピューティクス， インコーポレイティド | メタドンを含む胃内滞留システム |
| WO2022236288A1 (en) | 2021-05-05 | 2022-11-10 | Lyndra Therapeutics, Inc. | Gastric residence systems comprising buprenorphine and naloxone |
| AU2023209872A1 (en) | 2022-01-19 | 2024-08-01 | Nortiva Bio, Inc. | Dosage forms for gastric retention |
| CN120091832A (zh) | 2022-08-03 | 2025-06-03 | 林德拉治疗公司 | 用于胃驻留系统的金属芯部 |
| JP2025531626A (ja) | 2022-09-30 | 2025-09-22 | リンドラ セラピューティクス， インコーポレイティド | 胃内滞留システムを用いたリスペリドンの投与レジメン |
| US20240398701A1 (en) | 2023-06-02 | 2024-12-05 | Lyndra Therapeutics, Inc. | Manufacturing methods for gastric residence systems |
-
2020
- 2020-03-19 AU AU2020242062A patent/AU2020242062B2/en active Active
- 2020-03-19 JP JP2021556624A patent/JP2022525482A/ja not_active Withdrawn
- 2020-03-19 CN CN202080034566.XA patent/CN113840596A/zh active Pending
- 2020-03-19 EP EP20773419.5A patent/EP3941444B1/en active Active
- 2020-03-19 WO PCT/US2020/023710 patent/WO2020191231A1/en not_active Ceased
- 2020-03-19 US US17/593,437 patent/US12582608B2/en active Active
- 2020-03-19 CA CA3134186A patent/CA3134186A1/en active Pending
- 2020-03-19 MX MX2021011310A patent/MX2021011310A/es unknown
- 2020-03-19 BR BR112021018424A patent/BR112021018424A2/pt unknown
-
2021
- 2021-09-19 IL IL286510A patent/IL286510A/en unknown
-
2025
- 2025-01-16 JP JP2025006073A patent/JP2025067914A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP3941444A1 (en) | 2022-01-26 |
| CA3134186A1 (en) | 2020-09-24 |
| IL286510A (en) | 2021-10-31 |
| CN113840596A (zh) | 2021-12-24 |
| AU2020242062B2 (en) | 2025-12-11 |
| US20220192995A1 (en) | 2022-06-23 |
| BR112021018424A2 (pt) | 2021-11-23 |
| JP2025067914A (ja) | 2025-04-24 |
| EP3941444B1 (en) | 2025-03-26 |
| US12582608B2 (en) | 2026-03-24 |
| WO2020191231A1 (en) | 2020-09-24 |
| JP2022525482A (ja) | 2022-05-16 |
| AU2020242062A1 (en) | 2021-11-11 |
| EP3941444A4 (en) | 2023-01-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2021011310A (es) | Recubrimientos para formas de dosificacion de residencia gastrica. | |
| MX2025012985A (es) | Capsulas y recubrimientos de capsulas para formas de dosificacion de residencia gastrica | |
| EP4054545A4 (en) | Gastric residence systems for administration of active agents | |
| CR20210368A (es) | Combinación de dextrometorfano y bupropión para el tratamiento de depresión | |
| CN110869028A8 (zh) | 治疗猫冠状病毒感染的方法 | |
| EP4233902A3 (en) | Treatment of a disease of the gastrointestinal tract with an integrin inhibitor | |
| NZ740615A (en) | A pharmaceutical composition comprising electrohydrodynamically obtained fibres, the composition having improved residence time on the application site | |
| TR201908994T4 (tr) | Farmasötik bileşimler. | |
| EP4464363A3 (en) | Pharmaceutical dosage form for application to mucous membranes | |
| BR112017008993A2 (pt) | métodos e composições especificamente para o tratamento de transtorno de déficit de atenção | |
| WO2018165404A8 (en) | Pharmaceutical formulations of phloroglucinol and trimethylphloroglucinol | |
| CO2017002682A2 (es) | Composiciones y métodos para recubrimientos cannabinoides para uso en la entrega de fármacos | |
| WO2009106824A3 (en) | Pharmaceutical formulations with a taste masking coating | |
| EA201170117A1 (ru) | Противоаллергические биополимеры морского происхождения | |
| MX2019001032A (es) | Formulacion que tiene caracteristicas mejoradas de liberacion de farmacos ph dependientes, que contienen esomeprazol o una de sus sales farmaceuticas aceptable. | |
| BR112021026025A2 (pt) | Polímeros biodegradáveis ultrassensíveis ao ph | |
| UY37671A (es) | N-ariletil-2-aminoquinolin-4-carboxamidas sustituidas y su uso | |
| EP4470611A3 (en) | Levodopa and carbidopa intestinal gel and methods of use | |
| CN110809579A (zh) | 多肽的药学可接受的盐及其应用 | |
| CO2019000756A2 (es) | Recubrimientos fáciles de tragar y sustratos recubiertos con estos | |
| CY1121470T1 (el) | Μια μορφοποιηση φαρμακου καθυστερημενης εκλυσης | |
| BR112018071363A2 (pt) | composições farmacêuticas orais de nicotinamida | |
| EA201991667A1 (ru) | Экстренное лечение постоперационной тошноты и рвоты | |
| JOP20210075A1 (ar) | مشتقات 4-بيرازين-2-يل ميثيل-مورفولين واستخدامها كدواء | |
| JOP20200005B1 (ar) | تركيبات صيدلية |